165 related articles for article (PubMed ID: 35664780)
1. Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma.
Zhong F; Liu J; Gao C; Chen T; Li B
Front Oncol; 2022; 12():816070. PubMed ID: 35664780
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling.
Zhong F; Chen T; Li B
Biochem Biophys Res Commun; 2022 Sep; 622():170-176. PubMed ID: 35932528
[TBL] [Abstract][Full Text] [Related]
3. Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells.
Lee Y; Wu Z; Yang S; Schreiner SM; Gonzalez-Smith LD; Rhie SK
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291764
[TBL] [Abstract][Full Text] [Related]
4. Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration.
Qiu X; He H; Zeng H; Tong X; Zhang C; Liu Y; Liao Z; Liu Q
Genes Dis; 2024 May; 11(3):101004. PubMed ID: 38292182
[TBL] [Abstract][Full Text] [Related]
5. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
6. MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.
Musa J; Aynaud MM; Mirabeau O; Delattre O; Grünewald TG
Cell Death Dis; 2017 Jun; 8(6):e2895. PubMed ID: 28640249
[TBL] [Abstract][Full Text] [Related]
7. The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma.
Yang W; Chen H; Ma L; Wei M; Xue X; Li Y; Jin Z; Dong J; Xiao H
Heliyon; 2024 Mar; 10(6):e27772. PubMed ID: 38510035
[TBL] [Abstract][Full Text] [Related]
8. MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway.
Wei M; Yang R; Ye M; Zhan Y; Liu B; Meng L; Xie L; Du M; Wang J; Gao R; Chen D; Dong R; Dong K
Am J Cancer Res; 2022; 12(5):1960-1981. PubMed ID: 35693071
[TBL] [Abstract][Full Text] [Related]
9. High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
Guan Z; Cheng W; Huang D; Wei A
Curr Res Transl Med; 2018 Mar; 66(1):27-32. PubMed ID: 29274707
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
Le L; Luo J; Wu H; Chen L; Tang X; Fu F
Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782625
[TBL] [Abstract][Full Text] [Related]
11. A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2.
Vera O; Bok I; Jasani N; Nakamura K; Xu X; Mecozzi N; Angarita A; Wang K; Tsai KY; Karreth FA
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808771
[TBL] [Abstract][Full Text] [Related]
12. CENPA is one of the potential key genes associated with the proliferation and prognosis of ovarian cancer based on integrated bioinformatics analysis and regulated by MYBL2.
Han J; Xie R; Yang Y; Chen D; Liu L; Wu J; Li S
Transl Cancer Res; 2021 Sep; 10(9):4076-4086. PubMed ID: 35116705
[TBL] [Abstract][Full Text] [Related]
13. MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.
Ren F; Wang L; Shen X; Xiao X; Liu Z; Wei P; Wang Y; Qi P; Shen C; Sheng W; Du X
Am J Cancer Res; 2015; 5(4):1542-52. PubMed ID: 26101717
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
[TBL] [Abstract][Full Text] [Related]
15. PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer.
He Q; Ding Z; Chen T; Wu H; Song J; Xiang Z; Yang C; Wang S; Xiong B
Front Oncol; 2023; 13():1164070. PubMed ID: 37538116
[TBL] [Abstract][Full Text] [Related]
16. The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.
Li X; Zhang X; Wu CC; Li PP; Fu YM; Xie LH; Sun SS; Zhou YY; Zhu BL
J Mol Histol; 2021 Feb; 52(1):21-30. PubMed ID: 33141360
[TBL] [Abstract][Full Text] [Related]
17. MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer.
Jiao M; Zhang F; Teng W; Zhou C
Int J Gen Med; 2022; 15():3003-3030. PubMed ID: 35313552
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
19. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma.
Qin H; Li Y; Zhang H; Wang F; He H; Bai X; Li S
Onco Targets Ther; 2019; 12():1917-1927. PubMed ID: 30881043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
